Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Adma Biologics
(NQ:
ADMA
)
17.57
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
387
Open
17.57
Bid (Size)
15.00 (10)
Ask (Size)
17.80 (2)
Prev. Close
17.57
Today's Range
17.57 - 17.57
52wk Range
3.060 - 17.87
Shares Outstanding
196,357,149
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
August 14, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Assessing ADMA Biologics: Insights From 4 Financial Analysts
August 12, 2024
Via
Benzinga
Performance
YTD
+286.15%
+286.15%
1 Month
+31.22%
+31.22%
3 Month
+93.08%
+93.08%
6 Month
+229.64%
+229.64%
1 Year
+287.00%
+287.00%
More News
Read More
Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
August 11, 2024
Via
Benzinga
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
August 09, 2024
Via
Benzinga
How Is The Market Feeling About ADMA Biologics?
July 11, 2024
Via
Benzinga
Expert Ratings For ADMA Biologics
July 09, 2024
Via
Benzinga
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
June 20, 2024
Via
Benzinga
ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82
August 06, 2024
Via
Investor's Business Daily
ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
August 01, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Vir Biotechnology Stock Reaches 80-Plus RS Rating Benchmark
July 26, 2024
Via
Investor's Business Daily
Beam Therapeutics Stock Earns RS Rating Jump To 85
July 24, 2024
Via
Investor's Business Daily
Jim Cramer Recommends Not Selling Vertiv, Says Buy This Social Media Stock 'Hand Over Fist'
July 23, 2024
Via
Benzinga
Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
July 18, 2024
Via
Benzinga
Biotech Arvinas Stock Earns 82 RS Rating
July 17, 2024
Via
Investor's Business Daily
Denali Therapeutics Stock Gets Technical Rating Upgrade
July 16, 2024
Via
Investor's Business Daily
3 Millionaire-Making Stock Picks With Astounding Growth Potential
July 13, 2024
Via
InvestorPlace
Bull Run Alert: 3 Stocks Set to Soar in the Coming Months
July 11, 2024
Via
InvestorPlace
UroGen Pharma Stock Earns 91 RS Rating
June 27, 2024
Via
Investor's Business Daily
Arcellx Stock Earns Relative Strength Rating Upgrade
June 21, 2024
Via
Investor's Business Daily
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
June 20, 2024
Via
Investor's Business Daily
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
June 14, 2024
Via
Investor's Business Daily
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
June 12, 2024
Via
Investor's Business Daily
Krystal Biotech Stock Sees RS Rating Jump To 91
June 11, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.